Citrus Heights Mobile App Cross Platform Development
BASIC
- Around 5 Screens.
- Around 5 Integrations
- Only simple validations on device
- No-obligation inquiry.
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
STANDARD
- Around 10 Screens
- Around 10 Integrations
- Simple business logic for Validations / Calculations / Chart Data etc.
- Some local storage of data
- Team consists of: Dev Team - 1 Developer (full time) QA Team - 1 Test Engineer (shared)
- 1 Project Manager (shared)
- 1 Team Lead (shared)
PREMIUM
- Around 20 Screens
- Around 20 Integrations
- Complex business logic like Interactive Charts, Animations, Validations, Conditions etc.
- Complete local storage of data used by App
- We will create suggestions on monthly basis for improvement for you.
Cross-Platform App Development Services & Solutions in Citrus Heights
We take your groundwork and create a market-ready app based on your needs while you focus on product and company growth.
Flutter is the fastest-growing cross-platform development framework. It was introduced in 2017 by Google and managed to gain great popularity among cross-platform programmers.
Citrus Heights News
ATGC Biotech forms joint venture with Israeli firm
The exchange of licensing agreements was held at the Valedictory Session of the First International Science & Technology (S&T) Clusters Conference in New Delhi ...
ATGC Biotech and Luxembourg Industries form Indo–Israeli JV ‘Semiophore Ltd.’
ATGC Biotech, a leading Indian innovator in pheromone and semiochemical-based crop protection, on Tuesday announced the establishment of ‘Semiophore Ltd’, a 50:50 Indo–Israeli joint venture with ...
Fi Europe 2025: Raisio unlocks next-gen oat ingredients for health-forward F&B
Raisio Food Solutions’ innovation manager Tuire Wendelin shares how the newly commercialized FiprOat portfolio advances the company’s strategy to lead in science-driven oat innovation. Wendelin ...
ATGC Biotech, Israel's Luxembourg Industries form Semiophore crop-tech JV
The JV plans to commercialise 18 semiochemical and pheromone technologies developed by ATGC Biotech in multiple international markets, including Israel, Brazil, Australia and countries in Africa ...